A Randomized, Double-Blind, Placebo controlled Study Assessing the Long-term Effect of Dupilumab on Prevention of Lung Function Decline in Patients with Uncontrolled Moderate to Severe Asthma (LPS16676 (ATLAS))

Principal Investigator

Dr Nayia Petousi

Contact us

Email: catherine.borg@ouh.nhs.uk

Phone: 01865227242

IRAS number

1004110